PRKAA1 and type 2 diabetes mellitus: The therapeutic potential of AMPK activators to treat type 2 diabetes mellitus (T2DM) [8] was suggested when it was discovered that physical exercise activated AMPK in skeletal muscle, which led to increase glucose uptake.